The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP ...

Polyrizon (PLRZ) previously announced that it entered into a manufacturing agreement with Eurofins CDMO Amatsiaquitaine, a leading ...

Polyrizon Ltd. (NASDAQ: PLRZ) is undoubtedly a company to watch, as it moves closer to its clinical trial and continues to push the boundaries of innovation in the biotech field. With its cutting-edge ...

Shares of Polyrizon more than quadrupled intraday after the biotech company said it is moving forward with an allergy blocker clinical trial next year. The stock on Wednesday gained as much as 357% to ...

The school board is also considering having more EpiPens in stock for any student with an allergic reaction — even those ...

The PL-14 allergy blocker is part of Polyrizon’s effort to develop innovative nasal sprays that create a hydrogel-based ...

It starts with a stuffy nose, but soon your head feels like it’s caught in a vice. Nasal congestion and headaches often go ...

If you're running into the end of 2024 with a big FSA balance, don't fret. A long list of items and health services are FSA ...

You’ve probably heard a lot about your gut microbiome, but your nose microbiome may be wreaking havoc with your health as ...

Allergies can be easily managed at home. With early interventions, parents can help their children with allergies get through ...

ALK (ALKB:DC / OMX: ALK B) today announced positive interim results from its phase I/II clinical trial (named 'ALLIANCE') for its investigational sublingual immunotherapy ('SLIT') tablet for the ...

Is your cold medication safe? Here are 5 cold medications that you need to understand to get the most out of their safe and ...